News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fenwal Receives FDA Clearance for Therapeutic Plasma Exchange on Its Amicus® Separator


4/2/2012 10:30:57 AM

LAKE ZURICH, Ill.--(BUSINESS WIRE)--The U.S. Food and Drug Administration has cleared Fenwal to market a therapeutic plasma exchange protocol for the company’s Amicus® separator, Fenwal announced today.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES